{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T01:15:59Z","timestamp":1784337359114,"version":"3.55.0"},"reference-count":60,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T00:00:00Z","timestamp":1582588800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA138292"],"award-info":[{"award-number":["P30CA138292"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cancer Medicine"],"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>We developed a novel risk scoring system for urothelial cancer (UC) patients receiving immune checkpoint inhibitors (ICI).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a retrospective review of 67 UC patients treated with ICI at Winship Cancer Institute of Emory University from 2015 to 2018. Using stepwise variable selection in Cox proportional hazard model and Sullivan's weighting schema, baseline platelet\u2010to\u2010lymphocyte ratio (PLR), presence of liver metastasis, baseline albumin, and baseline Eastern Cooperative Oncology Group performance status (ECOG PS) were used for risk scoring. Patients were categorized into good risk (risk score 0\u20101), intermediate risk (risk score 2\u20103), and poor risk (risk score 4\u20106). Univariable (UVA) and multivariable analysis (MVA) and Kaplan\u2010Meier method were used to assess overall survival (OS) and progression free survival (PFS).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The Emory Risk Scoring System had C\u2010statistics of 0.74 (Standard Error\u00a0=\u00a00.047) in predicting OS and 0.70 (Standard Error\u00a0=\u00a00.043) in predicting PFS. Compared to good risk patients, poor risk patients had significantly shorter OS and PFS in both UVA and MVA (all <jats:italic>P<\/jats:italic>\u00a0&lt;\u00a0.001), and intermediate risk patients had significantly shorter OS and PFS in both UVA and MVA (all <jats:italic>P<\/jats:italic>\u00a0&lt;\u00a0.03).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Risk scoring using baseline PLR, presence of liver metastasis, baseline albumin, and baseline ECOG PS may effectively predict OS and PFS in UC patients receiving ICI.<\/jats:p><\/jats:sec>","DOI":"10.1002\/cam4.2932","type":"journal-article","created":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T02:44:16Z","timestamp":1582685056000},"page":"2752-2760","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors"],"prefix":"10.1002","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0991-9294","authenticated-orcid":false,"given":"Julie M.","family":"Shabto","sequence":"first","affiliation":[{"name":"Department of Hematology and Medical Oncology Emory University School of Medicine Atlanta GA USA"},{"name":"Winship Cancer Institute of Emory University Atlanta GA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0843-1222","authenticated-orcid":false,"given":"Dylan J.","family":"Martini","sequence":"additional","affiliation":[{"name":"Department of Hematology and Medical Oncology Emory University School of Medicine Atlanta GA USA"},{"name":"Winship Cancer Institute of Emory University Atlanta GA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Liu","sequence":"additional","affiliation":[{"name":"Departments of Biostatistics and Bioinformatics Emory University Atlanta GA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Ravindranathan","sequence":"additional","affiliation":[{"name":"Winship Cancer Institute of Emory University Atlanta GA USA"},{"name":"Department of Medicine Emory University Atlanta GA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Brown","sequence":"additional","affiliation":[{"name":"Department of Hematology and Medical Oncology Emory University School of Medicine Atlanta GA USA"},{"name":"Winship Cancer Institute of Emory University Atlanta GA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie E.","family":"Hitron","sequence":"additional","affiliation":[{"name":"Winship Cancer Institute of Emory University Atlanta GA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greta A.","family":"Russler","sequence":"additional","affiliation":[{"name":"Department of Hematology and Medical Oncology Emory University School of Medicine Atlanta GA USA"},{"name":"Winship Cancer Institute of Emory University Atlanta GA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Caulfield","sequence":"additional","affiliation":[{"name":"Department of Hematology and Medical Oncology Emory University School of Medicine Atlanta GA USA"},{"name":"Department of Pharmaceutical Services Emory University School of Medicine Atlanta GA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haydn","family":"Kissick","sequence":"additional","affiliation":[{"name":"Winship Cancer Institute of Emory University Atlanta GA USA"},{"name":"Department of Urology Emory University School of Medicine Atlanta GA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdad","family":"Alemozaffar","sequence":"additional","affiliation":[{"name":"Winship Cancer Institute of Emory University Atlanta GA USA"},{"name":"Department of Urology Emory University School of Medicine Atlanta GA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7715-3724","authenticated-orcid":false,"given":"Kenneth","family":"Ogan","sequence":"additional","affiliation":[{"name":"Winship Cancer Institute of Emory University Atlanta GA USA"},{"name":"Department of Urology Emory University School of Medicine Atlanta GA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne B.","family":"Harris","sequence":"additional","affiliation":[{"name":"Department of Hematology and Medical Oncology Emory University School of Medicine Atlanta GA USA"},{"name":"Winship Cancer Institute of Emory University Atlanta GA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7251-142X","authenticated-orcid":false,"given":"Viraj A.","family":"Master","sequence":"additional","affiliation":[{"name":"Department of Urology Emory University School of Medicine Atlanta GA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4755-0507","authenticated-orcid":false,"given":"Omer","family":"Kucuk","sequence":"additional","affiliation":[{"name":"Department of Hematology and Medical Oncology Emory University School of Medicine Atlanta GA USA"},{"name":"Winship Cancer Institute of Emory University Atlanta GA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley C.","family":"Carthon","sequence":"additional","affiliation":[{"name":"Department of Hematology and Medical Oncology Emory University School of Medicine Atlanta GA USA"},{"name":"Winship Cancer Institute of Emory University Atlanta GA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4003-1103","authenticated-orcid":false,"given":"Mehmet A.","family":"Bilen","sequence":"additional","affiliation":[{"name":"Department of Hematology and Medical Oncology Emory University School of Medicine Atlanta GA USA"},{"name":"Winship Cancer Institute of Emory University Atlanta GA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,2,25]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-17-0220"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.58.1041"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1703481"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.4155\/fsoa-2018-0033"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k793"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2015.07.111"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-0367"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.10.026"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.16866.1"},{"key":"e_1_2_10_11_1","unstructured":"MandrekarJN MandrekarSJ ChaSS.Cutpoint determination methods in survival analysis using SAS.Proceedings of the 28th SAS Users Group International Conference (SUGI).2003:261\u2010328."},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-9473(98)00096-6"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1742"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2016.03.031"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4154"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.4599"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31778"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-018-0315-0"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2017.01.013"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw016"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2017.07.024"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2017.12.015"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.12.022"},{"issue":"3","key":"e_1_2_10_24_1","first-page":"285","article-title":"A retrospective study of the natural history of patients with liver metastases from colorectal cancer","volume":"2","author":"Wood CB","year":"1976","journal-title":"Clin Oncol"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1177\/014107689108401207"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.36.15_suppl.9553"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-6073-7"},{"issue":"1","key":"e_1_2_10_28_1","first-page":"122","article-title":"Immunological Insights Into Liver Metastasis Associated Resistance To Checkpoint Blockade Cancer Immunotherapy","volume":"200","author":"Lee J","year":"2018","journal-title":"J Immunol"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.36.6_suppl.413"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.7_suppl.473"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0192227"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.2217\/imt.12.99"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.021908.132629"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-59745-518-3_5"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-16-0325"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8 <1614::AID-CNCR12>3.0.CO;2-2"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)41193-1"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.10.3173"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-016022"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2010.227"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0712671"},{"issue":"2","key":"e_1_2_10_42_1","first-page":"606","article-title":"Increase of regulatory T cells in the peripheral blood of cancer patients","volume":"9","author":"Wolf AM","year":"2003","journal-title":"Clin Cancer Res"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.bor.0000231909.35043.da"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/bonekey.2014.95"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1006\/jmbi.2000.4158"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2013.06.018"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.04.012"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2013.05.005"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jada.2004.05.213"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2891-9-69"},{"key":"e_1_2_10_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/bju.12240"},{"key":"e_1_2_10_52_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.12271"},{"key":"e_1_2_10_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2016.05.024"},{"key":"e_1_2_10_54_1","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S162066"},{"key":"e_1_2_10_55_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201344266"},{"key":"e_1_2_10_56_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.71.11.6648-6652.2003"},{"key":"e_1_2_10_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/0959-8049(95)00664-8"},{"key":"e_1_2_10_58_1","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2014.001457"},{"key":"e_1_2_10_59_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11020223"},{"key":"e_1_2_10_60_1","doi-asserted-by":"publisher","DOI":"10.1186\/1423-0127-16-30"},{"issue":"1","key":"e_1_2_10_61_1","first-page":"29","article-title":"Immunostimulatory monoclonal antibodies for hepatocellular carcinoma therapy","volume":"78","author":"Mazzolini GD","year":"2018","journal-title":"Trends Perspect"}],"container-title":["Cancer Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcam4.2932","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cam4.2932","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cam4.2932","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cam4.2932","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T05:41:30Z","timestamp":1755582090000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/cam4.2932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,25]]},"references-count":60,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["10.1002\/cam4.2932"],"URL":"https:\/\/doi.org\/10.1002\/cam4.2932","archive":["Portico"],"relation":{},"ISSN":["2045-7634","2045-7634"],"issn-type":[{"value":"2045-7634","type":"print"},{"value":"2045-7634","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,25]]},"assertion":[{"value":"2019-09-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-02-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-02-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}